Drug developer ADARx seeks $1.74 billion valuation in US IPO
finance.yahoo.com
21.09.2026 19:00
7 views
Related stories
Amazon and Shopify make starkly different moves in the brewing battle over AI shopping
marketwatch.com · 21.09
As the S&P 500 nears a new record high, there are cracks below the surface
marketwatch.com · 21.09
America’s power grid is running out of juice — and these stocks stand to gain
marketwatch.com · 21.09
Kremlin-backed forgery scheme moved $6.9bn through global banks
ft.com · 21.09
Elon Musk, Jensen Huang and Tim Cook are set to dine this week with Xi. Here’s what their companies want from China.
marketwatch.com · 21.09
The hottest part of the AI trade could be turning into its biggest weakness
marketwatch.com · 21.09